NCT04240600View on ClinicalTrials.gov

Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay

NAUnknownINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

December 1, 2021

Conditions
Acute Myeloid Leukemia, Adult
Interventions
DIETARY_SUPPLEMENT

Experimental group

2 cans or bottles (200ml)per day, orally

DIETARY_SUPPLEMENT

Control group

2 cans or bottles (200ml)per day, orally

Trial Locations (2)

06720

RECRUITING

Vannesa Fuchs Tarlovsky, Mexico City

06726

NOT_YET_RECRUITING

Hospital General de México, Mexico City

Sponsors

Collaborators (1)

Fresenius Kabi
All Listed Sponsors
collaborator

Fresenius Kabi

INDUSTRY

lead

Hospital General de Mexico

OTHER_GOV